Lipella Pharmaceuticals Inc.’s (NASDAQ:LIPO) Quiet Period To End on January 30th

Lipella Pharmaceuticals’ (NASDAQ:LIPOGet Rating) quiet period is set to end on Monday, January 30th. Lipella Pharmaceuticals had issued 1,217,391 shares in its IPO on December 20th. The total size of the offering was $6,999,998 based on an initial share price of $5.75. During Lipella Pharmaceuticals’ quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Lipella Pharmaceuticals Price Performance

Lipella Pharmaceuticals stock opened at $2.51 on Monday. Lipella Pharmaceuticals has a 52 week low of $2.44 and a 52 week high of $7.72.

Lipella Pharmaceuticals Company Profile

(Get Rating)

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. It focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella Pharmaceuticals Inc is based in PITTSBURGH.

Read More

Receive News & Ratings for Lipella Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lipella Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.